Quick Answer
SINOVAC BIOTECH LTD reported Revenue From Contract With Customer Excluding Assessed Tax of $448.27 million for the year ending 2023.
- SINOVAC BIOTECH LTD showed a decrease of -70.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2022 to 2023.
- This data is from SINOVAC BIOTECH LTD's annual report (Form 10-K), filed with the SEC on April 29, 2024.
- XBRL data for this metric is available from 2016 to 2023 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2016 to 2023), SINOVAC BIOTECH LTD's Revenue From Contract With Customer Excluding Assessed Tax has grown by 518.9%.
- Historical annual values: Fiscal year 2023: $448.27 million | Fiscal year 2022: $1.49 billion | Fiscal year 2021: $19.37 billion | Fiscal year 2020: $510.62 million | Fiscal year 2019: $246.05 million | Fiscal year 2018: $229.65 million | Fiscal year 2017: $3.89 million | Fiscal year 2017: $174.35 million | Fiscal year 2016: $72.43 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: